{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:18Z","timestamp":1792782618271,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["SC130125"],"award-info":[{"award-number":["SC130125"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Northwestern University Clinical and Translational Science Institute","award":["NUCATS"],"award-info":[{"award-number":["NUCATS"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00198-023-06811-w","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T07:02:11Z","timestamp":1686207731000},"page":"1637-1645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-7177","authenticated-orcid":false,"given":"Laura E.","family":"Crack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifaz T.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narina","family":"Simonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Gabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Brent","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"6811_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/TCRM.S72456","volume":"10","author":"AS Nazrun","year":"2014","unstructured":"Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN (2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 10:937\u2013948. https:\/\/doi.org\/10.2147\/TCRM.S72456","journal-title":"Ther Clin Risk Manag"},{"key":"6811_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00198-005-2028-8","volume":"17","author":"SD Jiang","year":"2006","unstructured":"Jiang SD, Dai LY, Jiang LS (2006) Osteoporosis after spinal cord injury. Osteoporos Int 17:180\u2013192. https:\/\/doi.org\/10.1007\/s00198-005-2028-8","journal-title":"Osteoporos Int"},{"key":"6811_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jbspin.2011.04.007","volume":"78","author":"C Alexandre","year":"2011","unstructured":"Alexandre C, Vico L (2011) Pathophysiology of bone loss in disuse osteoporosis. Jt Bone Spine 78:572\u2013576. https:\/\/doi.org\/10.1016\/j.jbspin.2011.04.007","journal-title":"Jt Bone Spine"},{"key":"6811_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2362.1990.tb01865.x","volume":"20","author":"F Biering-S\u00f8rensen","year":"1990","unstructured":"Biering-S\u00f8rensen F, Bohr HH, Schaadt OP (1990) Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 20:330\u2013335. https:\/\/doi.org\/10.1111\/j.1365-2362.1990.tb01865.x","journal-title":"Eur J Clin Invest"},{"key":"6811_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-008-0671-6","volume":"20","author":"LR Morse","year":"2009","unstructured":"Morse LR, Battaglino RA, Stolzmann KL et al (2009) Osteoporotic fractures and hospitalization risk in chronic spinal cord injury. Osteoporos Int 20:385\u2013392. https:\/\/doi.org\/10.1007\/s00198-008-0671-6","journal-title":"Osteoporos Int"},{"key":"6811_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1310\/NNXN-FT78-EAC6-A6EJ","volume":"11","author":"T Rogers","year":"2005","unstructured":"Rogers T, Shakes LK, Woodworth PH (2005) Pathologic extremity fracture care in spinal cord injury. Top Spinal Cord Inj Rehabil 11:70\u201378. https:\/\/doi.org\/10.1310\/NNXN-FT78-EAC6-A6EJ","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"6811_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.sc.3101909","volume":"45","author":"SS Brotherton","year":"2007","unstructured":"Brotherton SS, Krause JS, Nietert PJ (2007) Falls in individuals with incomplete spinal cord injury. Spinal Cord 45:37\u201340. https:\/\/doi.org\/10.1038\/sj.sc.3101909","journal-title":"Spinal Cord"},{"key":"6811_CR8","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.apmr.2020.05.016","volume":"101","author":"S Kirshblum","year":"2020","unstructured":"Kirshblum S, Botticello A, Benedetto J et al (2020) A comparison of diagnostic stability of the ASIA impairment scale versus frankel classification systems for traumatic spinal cord injury. Arch Phys Med Rehabil 101:1556\u20131562. https:\/\/doi.org\/10.1016\/j.apmr.2020.05.016","journal-title":"Arch Phys Med Rehabil"},{"key":"6811_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s004020000162","volume":"121","author":"D Sabo","year":"2001","unstructured":"Sabo D, Blaich S, Wenz W et al (2001) Osteoporosis in patients with paralysis after spinal cord injury. Arch Orthop Trauma Surg 121:75\u201378. https:\/\/doi.org\/10.1007\/s004020000162","journal-title":"Arch Orthop Trauma Surg"},{"key":"6811_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0003-9993(97)90032-0","volume":"78","author":"EG Pearson","year":"1997","unstructured":"Pearson EG, Nance PW, Leslie WD, Ludwig S (1997) Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil 78:269\u2013272. https:\/\/doi.org\/10.1016\/S0003-9993(97)90032-0","journal-title":"Arch Phys Med Rehabil"},{"key":"6811_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s001980070103","volume":"11","author":"L J\u00f8rgensen","year":"2000","unstructured":"J\u00f8rgensen L, Jacobsen BK, Wilsgaard T, Magnus JH (2000) Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study. Osteoporos Int 11:381\u2013387. https:\/\/doi.org\/10.1007\/s001980070103","journal-title":"Osteoporos Int"},{"key":"6811_CR12","doi-asserted-by":"publisher","unstructured":"Ma Z, Ma M, He Y et al (2022) Bisphosphonates alleviate bone loss in people with acute spinal cord injury: a systematic review and meta-analysis. World Neurosurg 1\u201312. https:\/\/doi.org\/10.1016\/j.wneu.2022.11.069","DOI":"10.1016\/j.wneu.2022.11.069"},{"key":"6811_CR13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1210\/jc.2006-2013","volume":"92","author":"NL Gilchrist","year":"2007","unstructured":"Gilchrist NL, Frampton CM, Acland RH et al (2007) Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 92:1385\u20131390. https:\/\/doi.org\/10.1210\/jc.2006-2013","journal-title":"J Clin Endocrinol Metab"},{"key":"6811_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1682\/JRRD.2004.05.0062","volume":"42","author":"WA Bauman","year":"2005","unstructured":"Bauman WA, Wecht JM, Kirshblum S et al (2005) Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev 42:305\u2013313. https:\/\/doi.org\/10.1682\/JRRD.2004.05.0062","journal-title":"J Rehabil Res Dev"},{"key":"6811_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0003-9993(99)90133-8","volume":"80","author":"PW Nance","year":"1999","unstructured":"Nance PW, Schryvers O, Leslie W et al (1999) Intravenous pamidronate attenuates bone density loss after acute spinal cord injury. Arch Phys Med Rehabil 80:243\u2013251. https:\/\/doi.org\/10.1016\/S0003-9993(99)90133-8","journal-title":"Arch Phys Med Rehabil"},{"key":"6811_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10067-010-1486-3","volume":"29","author":"M Maricic","year":"2010","unstructured":"Maricic M (2010) The role of zoledronic acid in the management of osteoporosis. Clin Rheumatol 29:1079\u20131084. https:\/\/doi.org\/10.1007\/s10067-010-1486-3","journal-title":"Clin Rheumatol"},{"key":"6811_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nrrheum.2010.96","volume":"6","author":"R Higgs","year":"2010","unstructured":"Higgs R (2010) Osteoporosis: zoledronic acid for osteoporosis treatmenta matter of time. Nat Rev Rheumatol 6:382. https:\/\/doi.org\/10.1038\/nrrheum.2010.96","journal-title":"Nat Rev Rheumatol"},{"key":"6811_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T et al (2007) Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int 80:316\u2013322. https:\/\/doi.org\/10.1007\/s00223-007-9012-6","journal-title":"Calcif Tissue Int"},{"key":"6811_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00198-010-1221-6","volume":"22","author":"JS Bubbear","year":"2011","unstructured":"Bubbear JS, Gall A, Middleton FRI et al (2011) Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury. Osteoporos Int 22:271\u2013279. https:\/\/doi.org\/10.1007\/s00198-010-1221-6","journal-title":"Osteoporos Int"},{"key":"6811_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00774-014-0602-x","volume":"33","author":"WA Bauman","year":"2015","unstructured":"Bauman WA, Cirnigliaro CM, La Fountaine MF et al (2015) Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study. J Bone Miner Metab 33:410\u2013421. https:\/\/doi.org\/10.1007\/s00774-014-0602-x","journal-title":"J Bone Miner Metab"},{"key":"6811_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.pmrj.2016.01.012","volume":"8","author":"TJ Schnitzer","year":"2016","unstructured":"Schnitzer TJ, Kim K, Marks J et al (2016) Zoledronic acid treatment after acute spinal cord injury: results of a randomized, placebo-controlled pilot trial. PM R 8:833\u2013843. https:\/\/doi.org\/10.1016\/j.pmrj.2016.01.012","journal-title":"PM R"},{"key":"6811_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41393-020-0431-9","volume":"58","author":"CV Oleson","year":"2020","unstructured":"Oleson CV, Marino RJ, Formal CS et al (2020) The effect of zoledronic acid on attenuation of bone loss at the hip and knee following acute traumatic spinal cord injury: a randomized-controlled study. Spinal Cord 58:921\u2013929. https:\/\/doi.org\/10.1038\/s41393-020-0431-9","journal-title":"Spinal Cord"},{"key":"6811_CR23","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41393-018-0195-7","volume":"56","author":"S Goenka","year":"2018","unstructured":"Goenka S, Sethi S, Pandey N et al (2018) Effect of early treatment with zoledronic acid on prevention of bone loss in patients with acute spinal cord injury: a randomized controlled trial. Spinal Cord 56:1207\u20131211. https:\/\/doi.org\/10.1038\/s41393-018-0195-7","journal-title":"Spinal Cord"},{"key":"6811_CR24","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/jbmr.4416","volume":"36","author":"WB Edwards","year":"2021","unstructured":"Edwards WB, Haider IT, Simonian N et al (2021) Durability and delayed treatment effects of zoledronic acid on bone loss after spinal cord injury: a randomized, controlled trial. J Bone Miner Res 36:2127\u20132138. https:\/\/doi.org\/10.1002\/jbmr.4416","journal-title":"J Bone Miner Res"},{"key":"6811_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00198-013-2419-1","volume":"25","author":"D Lala","year":"2014","unstructured":"Lala D, Craven BC, Thabane L et al (2014) Exploring the determinants of fracture risk among individuals with spinal cord injury. Osteoporos Int 25:177\u2013185. https:\/\/doi.org\/10.1007\/s00198-013-2419-1","journal-title":"Osteoporos Int"},{"key":"6811_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.sc.3101223","volume":"39","author":"PL Ditunno","year":"2001","unstructured":"Ditunno PL, Ditunno JF (2001) Walking index for spinal cord injury (WISCI II): scale revision. Spinal Cord 39:654\u2013656","journal-title":"Spinal Cord"},{"key":"6811_CR27","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00198-013-2323-8","volume":"24","author":"WB Edwards","year":"2013","unstructured":"Edwards WB, Schnitzer TJ, Troy KL (2013) Bone mineral loss at the proximal femur in acute spinal cord injury. Osteoporos Int 24:2461\u20132469. https:\/\/doi.org\/10.1007\/s00198-013-2323-8","journal-title":"Osteoporos Int"},{"key":"6811_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S8756-3282(97)00072-0","volume":"21","author":"TF Lang","year":"1997","unstructured":"Lang TF, Keyak JH, Heitz MW et al (1997) Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. Bone 21:101\u2013108. https:\/\/doi.org\/10.1016\/S8756-3282(97)00072-0","journal-title":"Bone"},{"key":"6811_CR29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1359\/JBMR.040307","volume":"19","author":"T Lang","year":"2004","unstructured":"Lang T, LeBlanc A, Evans H et al (2004) Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res 19:1006\u20131012. https:\/\/doi.org\/10.1359\/JBMR.040307","journal-title":"J Bone Miner Res"},{"key":"6811_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00198-013-2557-5","volume":"25","author":"WB Edwards","year":"2014","unstructured":"Edwards WB, Schnitzer TJ, Troy KL (2014) Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury. Osteoporos Int 25:1005\u20131015. https:\/\/doi.org\/10.1007\/s00198-013-2557-5","journal-title":"Osteoporos Int"},{"key":"6811_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0021-9290(93)90014-6","volume":"26","author":"M Dalstra","year":"1993","unstructured":"Dalstra M, Huiskes R, Odgaard A, van Erning L (1993) Mechanical and textural properties of pelvic trabecular bone. J Biomech 26:523\u2013535. https:\/\/doi.org\/10.1016\/0021-9290(93)90014-6","journal-title":"J Biomech"},{"key":"6811_CR32","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1359\/jbmr.080805","volume":"23","author":"TM Keaveny","year":"2008","unstructured":"Keaveny TM, Hoffmann PF, Singh M et al (2008) Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res 23:1974\u20131982. https:\/\/doi.org\/10.1359\/jbmr.080805","journal-title":"J Bone Miner Res"},{"key":"6811_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bone.2008.11.014","volume":"44","author":"JH Keyak","year":"2009","unstructured":"Keyak JH, Koyama AK, LeBlanc A et al (2009) Reduction in proximal femoral strength due to long-duration spaceflight. Bone 44:449\u2013453. https:\/\/doi.org\/10.1016\/j.bone.2008.11.014","journal-title":"Bone"},{"key":"6811_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2106\/00004623-199503000-00008","volume":"77","author":"AC Courtney","year":"1995","unstructured":"Courtney AC, Wachtel EF, Myers ER, Hayes WC (1995) Age-related reductions in the strength of the femur tested in a fall- loading configuration. J Bone Jt Surg 77:387\u2013395. https:\/\/doi.org\/10.2106\/00004623-199503000-00008","journal-title":"J Bone Jt Surg"},{"key":"6811_CR35","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0021-9290(00)00069-5","volume":"33","author":"DC Wirtz","year":"2000","unstructured":"Wirtz DC, Schiffers N, Forst R et al (2000) Critical evaluation of known bone material properties to realize anisotropic FE-simulation of the proximal femur. J Biomech 33:1325\u20131330. https:\/\/doi.org\/10.1016\/S0021-9290(00)00069-5","journal-title":"J Biomech"},{"key":"6811_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/jbmr.091033","volume":"25","author":"TM Keaveny","year":"2010","unstructured":"Keaveny TM, Kopperdahl DL, Melton LJ et al (2010) Age-dependence of femoral strength in white women and men. J Bone Miner Res 25:994\u20131001. https:\/\/doi.org\/10.1002\/jbmr.091033","journal-title":"J Bone Miner Res"},{"key":"6811_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","volume":"25","author":"MFX Gnant","year":"2007","unstructured":"Gnant MFX, Mlineritsch B, Luschin-Ebengreuth G et al (2007) Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 25:820\u2013828. https:\/\/doi.org\/10.1200\/JCO.2005.02.7102","journal-title":"J Clin Oncol"},{"key":"6811_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00198-015-3333-5","volume":"27","author":"L Gifre","year":"2016","unstructured":"Gifre L, Vidal J, Carrasco JL et al (2016) Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury. Osteoporos Int 27:405\u2013410. https:\/\/doi.org\/10.1007\/s00198-015-3333-5","journal-title":"Osteoporos Int"},{"key":"6811_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbm4.10375","volume":"4","author":"CM Cirnigliaro","year":"2020","unstructured":"Cirnigliaro CM, La Fountaine MF, Parrott JS et al (2020) Administration of denosumab preserves bone mineral density at the knee in persons with subacute spinal cord injury: findings from a randomized clinical trial. JBMR Plus 4:1\u201311. https:\/\/doi.org\/10.1002\/jbm4.10375","journal-title":"JBMR Plus"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06811-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T04:04:15Z","timestamp":1692072255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6811"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06811-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W. Brent Edwards has received research funding and speaker fees from Amgen. Thomas J. Schnitzer has received research funding from Radius, Amgen, Eli Lilly, and Pfizer as well as consulting fees from Eli Lilly and Pfizer. Laura E. Crack, Ifaz T. Haider, Narina Simonian, Joana Barroso, and Leigh Gabel have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}